There is a need to support men to make informed decisions about prostate-specific antigen testing using appropriate information resources and decision aids.

When detected early, nine in 10 Australians with bowel cancer can be successfully treated, yet participation in the National Bowel Cancer Screening Program remains low.

The aim of this article is to provide an overview of the nonavalent HPV vaccine, the rationale for its use, and the updated dose scheduling requirements for HPV vaccine.

Australia has adopted innovative, evidence-based criteria for the inclusion of HPV NAT assays in the renewed NCSP.

Expected frequency trees can be used to promote appropriate patient choice of colorectal cancer screening modality.

Prescribing drugs to reduce the risk of cancer is a new development in primary cancer prevention.

A diagnosis of cancer disrupts almost every developmental life stage and continues to affect the child, and potentially their whole family, throughout adulthood.

This model of care recommends a systemic, coordinated, multidisciplinary approach to survivorship, using pathways of care that support wellness, disease prevention and cancer surveillance.

How should GPs and patients prioritise which preventive health activities to undertake?

At-home screening and risk stratification are strategies that can be employed at times of disruption to maintain adequate levels of cancer prevention and early detection.